BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25015721)

  • 1. Interleukin-17 is a favorable prognostic marker for colorectal cancer.
    Lin Y; Xu J; Su H; Zhong W; Yuan Y; Yu Z; Fang Y; Zhou H; Li C; Huang K
    Clin Transl Oncol; 2015 Jan; 17(1):50-6. PubMed ID: 25015721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
    Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
    Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
    Gao JY; Song BR; Peng JJ; Lu YM
    World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
    Zheng L; Xie G; Duan G; Yan X; Li Q
    PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of nomograms integrating IL-37 expression, neutrophil level, and MMR status in patients with colorectal cancer.
    Zhu B; Luo J; Jiang Y; Yu L; Liu M; Fu J
    Cancer Med; 2018 Aug; 7(8):3682-3694. PubMed ID: 30004182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.
    Cui G; Yuan A; Goll R; Florholmen J
    Scand J Gastroenterol; 2012 Nov; 47(11):1304-12. PubMed ID: 22989213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.
    Cui G; Yuan A; Li Z; Goll R; Florholmen J
    Sci Rep; 2020 Apr; 10(1):5892. PubMed ID: 32246094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.
    Peng L; Tu P; Wang X; Shi S; Zhou X; Wang J
    J Mol Histol; 2014 Oct; 45(5):555-63. PubMed ID: 24912672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of TSP50, SERCA2 and IL-8 in Colorectal Adenoma and Carcinoma: Correlation to Clinicopathological Factors.
    Youssef HMK; Radi DA; Abd El-Azeem MA
    Pathol Oncol Res; 2021; 27():1609990. PubMed ID: 34744521
    [No Abstract]   [Full Text] [Related]  

  • 11. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
    Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
    Jiang Z; Xu Y; Cai S
    Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of interleukin-21 along colorectal adenoma-carcinoma sequence and its predicating significance in patients with sporadic colorectal cancer.
    Cui G; Yuan A; Zhu L; Florholmen J; Goll R
    Clin Immunol; 2017 Oct; 183():266-272. PubMed ID: 28887120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathological significance of REIC expression in colorectal carcinomas.
    Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and prognostic significance of androgen receptor overexpression in colorectal cancer. Experience from Al-Madinah Al-Munawarah, Saudi Arabia.
    Albasri AM; Elkablawy MA
    Saudi Med J; 2019 Sep; 40(9):893-900. PubMed ID: 31522216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
    Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
    Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer.
    Cui G; Qi H; Gundersen MD; Yang H; Christiansen I; Sørbye SW; Goll R; Florholmen J
    Cancer Immunol Immunother; 2015 Feb; 64(2):181-90. PubMed ID: 25324197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.